The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy Virtual 2020 | A CAR-T round-up with Arnon Nagler
CAR T-cell therapy is revolutionizing the treatment of hematological malignancy. Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses CAR-T approaches to the treatment of acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma and multiple myeloma,. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
